Overview

Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)

Status:
Unknown status
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to validate the first round HCV early dynamics discovery within a larger population.
Details
Lead Sponsor:
Junqi Niu
Collaborator:
Chinese Academy of Sciences
Treatments:
Interferon alpha-2
Interferon-alpha
Interferons
Ribavirin